Circulatory System smokers
Conditions
Interventions
Group M ( n = 40): will receive magnesium sulfate 50 mg/kg in a total volume 100 ml of normal saline
Group N ( n = 40 ): will receive nalbuphine 0.2mg/kg in a total volume 100 ml of normal saline over
Sponsors
doaa rashwan
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: The study population will include inpatients of the involved departments including neurosurgery, general, urology, ENT, plastic and orthopedic surgery, both sex, selected randomly according to American Society of Anesthesiologists(ASA) grade I , between the ages of 18-50 years.
Exclusion criteria
Exclusion criteria: Exclusion criteria: - History or suspected difficult airway. - ASA physical status other than I. - Patients undergoing cardiac and neurosurgical procedures. - History of uncontrolled hypertension, myocardial ischemia, arrhythmias uncontrolled diabetes mellitus and cerebrovascular stroke. - Bronchial asthma. - Renal disease, liver dysfunction, pregnancy. - Patients on hypnotic or narcotic analgesic. - History of alcohol or drug abuse. - History of allergic reaction to opioids or any drug used in this study - Patients in whom the duration of laryngoscopy exceeded 30 seconds.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| mean arterial blood pressure | — |
Secondary
| Measure | Time frame |
|---|---|
| heart rate | — |
Countries
Egypt
Contacts
Public Contactdoaa rashwan
assitant professor
Outcome results
None listed